UBIGENE

EZ-editor™ KO Cell Lysate | Ubigene

EZ-editor™ KO Cell Lysate

The Gold Standard for Antibody Validation

EZ-editor™ KO Cell Lysate

10,000+ KO Cell Models Powering Antibody Specificity Validation

KO Cell Lysates

The Benchmark Tool for Gene Knockout-Based Antibody Validation

Knockout (KO) cell lysates are built on gene-edited cell line models that provide an ideal negative control system through the specific ablation of a target gene. Unlike traditional knockdown models, KO models eliminate the confounding effects of residual protein expression. By comparing detection signals between WT and KO samples, researchers can directly evaluate an antibody's target recognition specificity, making it the gold standard for antibody validation. Ubigene builds KO cell models using the EZ-editor™ platform, verifies knockout efficiency via Sanger sequencing or Western Blot (WB), and prepares standardized, ready-to-use KO protein lysates.

EZ-editor™ KO Cell Lysate Products

Ubigene provides over 10,000 monoclonal KO cell lysate products to meet diverse target validation needs. All lines are validated by Sanger sequencing or WB. Researchers can obtain standardized, ready-to-use KO protein samples without complex experimental workflows, directly accelerating antibody specificity verification, screening, and protein function studies. If you cannot find your target, custom services are available—contact us for details.

KO antibody illustration

KO Cell Lysate (Monoclonal)

In stock
KO Lysate: 150ug/vial/gene
WT Lysate: 10ug/vial/gene (Free)
Starting from
$170 per Lysate
Custom
KO Lysate: 150ug/vial/gene
WT Lysate: 10ug/vial/gene (Free)
Starting from
$480 per Lysate

Knockout (KO) Cell Lines

10000+
Starting from
$1490 per Lysate
Inventory Search

KO Cell Models: The Gold Standard for antibody validation

Accurately Differentiating Specific Signals from Non-Specific Backgrounds

Antibody specificity directly impacts experimental accuracy and reliability, yet non-specific binding, cross-reactivity, and batch-to-batch variations remain common challenges. Traditional siRNA methods struggle with incomplete target deletion due to efficiency limits, which can compromise specificity assessments. KO cell models achieve complete target protein ablation via gene knockout, serving as reliable negative controls. Comparing signal differences between WT and KO samples allows for precise evaluation of antibody specificity and effectively rules out background interference. Currently, KO validation is widely applied in WB, immunoassays, and protein function research.

Comparison of Validation Effect Across Different Models

Comparison Metrics siRNA Knockdown Model KO Cell Lysate (Cell Pool) KO Cell Lysate (Monoclonal)
Action LevelRNA-level knockdownDNA-level gene knockoutDNA-level gene knockout
Target Protein ExpressionPartially reducedSignificantly reduced/absentAbsent
Negative Control ReliabilityLow★★★★★High★★★★★Higher★★★★★
Antibody Specificity ValidationLimitedGoodGold Standard 👍
Non-Specific Signal ExclusionWeakStrongStronger 😊
Cell Population HomogeneityTransfection efficiency-dependentCellular heterogeneity existsSingle clone, uniform & stable
Experimental ReproducibilitySusceptible to conditionsRelatively stableHighly stable
Applicable ScenariosPreliminary gene function studiesRapid screening & preliminary validationAntibody development, performance evaluation, publication-grade validation

Ubigene Antibody Validation Case Studies

Powered by the EZ-editor™ platform and a repository of over 10,000 KO cell models, Ubigene has partnered with multiple antibody companies to provide high-quality KO cell lysates and custom validation services. By constructing target-deficient models and analyzing WT/KO signal differences, we help clients precisely evaluate antibody specificity and detection reliability, boosting product quality and accelerating translational applications.

FAQs

1. How are Ubigene's knockout (KO) cell lines constructed?
Built using CRISPR/Cas gene-editing technology and validated via Sanger sequencing or Western Blot (WB) to obtain stable, monoclonal KO lines. Ubigene features over 10,000 KO cells, spanning 500+ cell types, 5,000+ gene targets, 26 classic signaling pathways, 5 major drug target categories, and 27 disease models, with a focus on oncology research. Each line comes with an STR authentication report and is tested against 75 common mycoplasma strains to ensure zero contamination, stability, and high viability.
2. How should KO cell lysates be stored upon receipt?
3. Can I use my own wild-type cell lines?
4. Are the cell lysates denatured or native?

Contact Us

Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.

* Name

* Email

* Institution

* Products & Services of Interest

If email is not available, how else can we reach you?

How did you hear about us?

to-top
Logo
E-mail: info@ubigene.com
WhatsAPP: +86 153 6067 3248
TEL: +86 153 6067 3248(Int'l)
Copyright © 2025 Ubigene. All rights reserved.